With cannabis moving to Schedule III, the industry is entering a world built around pharmaceutical-grade expectations. Drying, curing, and storage are no longer “art and intuition” they become controlled, validated manufacturing steps subject to GMP-style oversight.
Cultivators who can demonstrate consistency, documentation, and microbial control will be positioned to supply future medical, pharmaceutical, and export markets. Cannatrol® with Vaportrol® technology delivers that advantage.